Literature DB >> 16873771

A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital.

Ravisekhar Gadepalli1, Benu Dhawan, Vishnubhatla Sreenivas, Arti Kapil, A C Ammini, Rama Chaudhry.   

Abstract

OBJECTIVE: To determine the microbiological profile and antibiotic susceptibility patterns of organisms isolated from diabetic foot ulcers. Also, to assess potential risk factors for infection of ulcers with multidrug-resistant organisms (MDROs) and the outcome of these infections. RESEARCH DESIGN AND METHODS: Pus samples for bacterial culture were collected from 80 patients admitted with diabetic foot infections. All patients had ulcers with Wagner's grade 3-5. Fifty patients (62.5%) had coexisting osteomyelitis. Gram-negative bacilli were tested for extended spectrum beta-lactamase (ESBL) production by double disc diffusion method. Staphylococcal isolates were tested for susceptibility to oxacillin by screen agar method, disc diffusion, and mec A-based PCR. Potential risk factors for MDRO-positive samples were explored.
RESULTS: Gram-negative aerobes were most frequently isolated (51.4%), followed by gram-positive aerobes and anaerobes (33.3 and 15.3%, respectively). Seventy-two percent of patients were positive for MDROs. ESBL production and methicillin resistance was noted in 44.7 and 56.0% of bacterial isolates, respectively. MDRO-positive status was associated with presence of neuropathy (P = 0.03), osteomyelitis (P = 0.01), and ulcer size >4 cm(2) (P < 0.001) but not with patient characteristics, ulcer type and duration, or duration of hospital stay. MDRO-infected patients had poor glycemic control (P = 0.01) and had to be surgically treated more often (P < 0.01).
CONCLUSIONS: Infection with MDROs is common in diabetic foot ulcers and is associated with inadequate glycemic control and increased requirement for surgical treatment. There is a need for continuous surveillance of resistant bacteria to provide the basis for empirical therapy and reduce the risk of complications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16873771     DOI: 10.2337/dc06-0116

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  57 in total

1.  Multidrug-resistant organisms, wounds and topical antimicrobial protection.

Authors:  Philip G Bowler; Sarah Welsby; Victoria Towers; Rebecca Booth; Andrea Hogarth; Victoria Rowlands; Alexis Joseph; Samantha A Jones
Journal:  Int Wound J       Date:  2012-05-29       Impact factor: 3.315

2.  Association of complement C3 and interleukin-1 with foot infections in diabetic patients.

Authors:  Z M H Kheiralla; S S Maklad; S M Ashour; E El-Sayed Moustafa
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

Review 3.  Diabetic foot infections: microbiological aspects, current and future antibiotic therapy focusing on methicillin-resistant Staphylococcus aureus.

Authors:  Andreas Ambrosch; Simone Haefner; Edward Jude; Ralf Lobmann
Journal:  Int Wound J       Date:  2011-08-23       Impact factor: 3.315

Review 4.  The microbiologic profile of diabetic foot infections in Turkey: a 20-year systematic review: diabetic foot infections in Turkey.

Authors:  M Hatipoglu; M Mutluoglu; G Uzun; E Karabacak; V Turhan; B A Lipsky
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-23       Impact factor: 3.267

Review 5.  Choice of wound care in diabetic foot ulcer: A practical approach.

Authors:  Karakkattu Vijayan Kavitha; Shalbha Tiwari; Vedavati Bharat Purandare; Sudam Khedkar; Shilpa Sameer Bhosale; Ambika Gopalakrishnan Unnikrishnan
Journal:  World J Diabetes       Date:  2014-08-15

6.  Spectrum of bacteria associated with diabetic foot ulcer and biofilm formation: A prospective study.

Authors:  Asima Banu; Mir Mohammad Noorul Hassan; Janani Rajkumar; Sathyabheemarao Srinivasa
Journal:  Australas Med J       Date:  2015-09-30

7.  Interaction of dihydrofolate reductase and aminoglycoside adenyltransferase enzyme from Klebsiella pneumoniae multidrug resistant strain DF12SA with clindamycin: a molecular modelling and docking study.

Authors:  Shailesh K Shahi; Vinay K Singh; Ashok Kumar; Sanjeev K Gupta; Surya K Singh
Journal:  J Mol Model       Date:  2012-10-25       Impact factor: 1.810

8.  A Study on Acinetobacter baumannii and Staphylococcus aureus Strains Recovered from the Same Infection Site of a Diabetic Patient.

Authors:  Nancy Castellanos; Jun Nakanouchi; Dennis Irfan Yüzen; Sammie Fung; Jennifer S Fernandez; Claudia Barberis; Lorena Tuchscherr; Maria Soledad Ramirez
Journal:  Curr Microbiol       Date:  2019-05-03       Impact factor: 2.188

Review 9.  Management of osteomyelitis of the foot in diabetes mellitus.

Authors:  Fran Game
Journal:  Nat Rev Endocrinol       Date:  2010-01       Impact factor: 43.330

Review 10.  MRSA and diabetic foot wounds: contaminating or infecting organisms?

Authors:  Frank L Bowling; Edward B Jude; Andrew J M Boulton
Journal:  Curr Diab Rep       Date:  2009-12       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.